MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Subthalamic nucleus(SIN)"

  • 2017 International Congress

    Information transfer between subthalamic area and forearm muscles during tonic muscle activity in Parkinson’s patients

    I. Weber, E. Florin, M. von Papen, L. Timmermann (Marburg, Germany)

    Objective: We compare information transfer between forearm muscles and two subthalamic regions, namely the subthalamic nucleus (STN) and the zona incerta (ZI), during an isometric…
  • 2017 International Congress

    UPDRS benefit from dual frequency DBS fields sculpted by intentionally overlapped interleaving

    Y. Fernandez, D. Caputo, D. Schneider, R. Dipaola, S. Danish, E. Hargreaves (New York, NY, USA)

    Objective: We show that UPDRS-III scores after interleaving compared to those prior to interleaving reflect a gain in benefit by lowered scores. Background: Previously, we…
  • 2017 International Congress

    Outcomes of a Prospective, Multicenter International Registry of Deep Brain Stimulation for Parkinson’s Disease

    G. Deuschl, R. Jain, H. Scholtes, K. Steinke, A. Wang, A. Kühn, L. Timmermann, M. Pötter-Nerger, P. Eldridge, J. Volkmann, J. Fitzgerald, A. Schnitzler, H. Mehdorn, J. Vesper (Kiel, Germany)

    Objective: To investigate the effectiveness and safety-related real-world outcomes of a multiple-source, constant current Deep Brain Stimulation (DBS) System in the treatment of levodopa-responsive Parkinson’s…
  • 2017 International Congress

    Efficacy and tolerability of low-frequency deep brain stimulation during daytime only in Parkinson’s disease: a pilot study

    F. Dematteis, M. Zibetti, E. Montanaro, L. Rizzi, M. Lanotte, L. Lopiano, M. Rizzone (Torino, Italy)

    Objective: To compare the efficacy and tolerability of low-frequency stimulation (LFS) during daytime only to LFS applied 24 hours a day, in PD patients bilaterally…
  • 2017 International Congress

    Real World Clinical Outcomes Using a Novel Directional Lead from a Multicenter Registry of DBS for Parkinson’s disease

    G. Deuschl, R. Jain, H. Scholtes, K. Steinke, A. Wang, M. Pötter-Nerger, L. Timmermann, J. Volkmann, A. Kühn, P. Eldridge, J. Fitzgerald, H. Mehdorn, J. Vesper (Kiel, Germany)

    Objective: To evaluate clinical outcomes in subjects implanted with a Directional Lead for use in the treatment of levodopa-responsive Parkinson’s disease (PD) as part of…
  • 2016 International Congress

    A new tool to measure the impact of deep brain stimulation on Parkinson’s disease patients: Development and validation of the deep brain stimulation impairment scale (DBS-IS)

    F. Maier, C.J. Lewis, A.A. Kühn, H. Krug, J. Volkmann, A.D. Kirsch, L. Wojtecki, A. Schnitzler, G. Deuschl, J.K. Krauss, C. Woopen, L. Timmermann (Cologne, Germany)

    Objective: To develop a questionnaire that measures impairments related to deep brain stimulation (DBS). Background: DBS has considerable influence on motor and non-motor symptoms in…
  • 2016 International Congress

    Implantable pulse generator (IPG) longevity decreases following each replacement surgery in Parkinson’s disease (PD) patients treated with bilateral sub-thalamic nucleus deep brain stimulation (STN-DBS)

    S.D. Israeli-Korn, S. Tessler, G. Yahalom, S. Benizri, O.S. Cohen, C. Shabat, H. Strauss, N. Warmann-Alaluf, E. Stein, Z. Zibly, R. Spiegelman, S. Hassin (Ramat Gan, Israel)

    Objective: To investigate the influence of the number of implantable pulse generator (IPG) replacement surgeries and the IPG model on battery life in bilateral STN…
  • 2016 International Congress

    The contribution of the subthalamic nucleus in gait initiation of subjects with Parkinson’s disease

    C. Palmisano, G. Arnulfo, N.G. Pozzi, A. Canessa, A. Leporini, C.A. Frigo, G. Pezzoli, F. Steigerwald, J. Volkmann, I.U. Isaias (Wuerzburg, Germany)

    Objective: We investigated the contribution of the subthalamic nucleus (STN) in gait initiation of subjects with Parkinson's disease (PD). Background: Gait initiation is the transient…
  • 2016 International Congress

    Unilateral subthalamotomy in Parkinson´s disease: Cognitive and neuropsychiatric effects and correlation with lesion size

    I. Obeso, E. Casabona, R. Rodríguez-Rojas, N. Pavón, R. Macías, M.L. Bringas, J.A. Obeso, M. Jahanshahi (Madrid, Spain)

    Objective: To assess cognitive and neuropsychiatric effects of unilateral subthalamotomy in Parkinson´s disease (PD) and their correlation with lesion size. Background: Surgery for treatment of…
  • 2016 International Congress

    Chronic directional subthalamic nucleus deep brain stimulation in Parkinson’s disease – A pilot study

    P. Reker, T.A. Dembek, A. Gierich, J. Wirths, H.S. Dafsari, J. Roediger, M.T. Barbe, L. Timmermann, V. Visser-Vandewalle (Cologne, Germany)

    Objective: This pilot study aimed to assess the therapeutic potential of chronically implanted directional DBS leads in patients with Parkinson's disease. Background: The therapeutic effect…
  • « Previous Page
  • 1
  • …
  • 26
  • 27
  • 28
  • 29
  • 30
  • …
  • 35
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley